Rapiblyk Injection, Powder, Lyophilized, For Solution
Product Images NDC 84381-110

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rapiblyk (NDC 84381-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aop Orphan Pharmaceuticals Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structuralformula (Image11)

Chemical structure of landiolol hydrochloride, showing its molecular components including a benzene ring, ester groups, and a morpholine ring.*

FDA Label Image

Carton Rapiblyk (Carton)

Packaging label for RAPIBLYK 280 mg/vial (landiolol) injection, powder, lyophilized for solution for intravenous infusion. The label states it is a single-dose vial and instructs to discard unused portion. It includes storage instructions, manufacturer details (AOP Orphan Pharmaceuticals GmbH), and NDC code 84381-110. The label also notes reconstitution with 50 mL diluent and absence of preservatives.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.